Abstract:Objective To explore the long-term effects of risk-based stratification treatment of children with medulloblastoma and elucidate the relationship between risk factors,treatment effects and prognosis.Methods Patients admitted from January 2010 to June 2015 with primary medulloblastoma confirmed by postoperative histopathology were stratified into low-risk or high-risk group.They were stratified on the basis of risk factors,i.e.age,Chang et al's staging system (no metastasis M0,with metastasis M +),complete/near total tumor resection and postoperative residue tumor (tumor residue ≥ 1.5 cm).pathological type (classical medulloblastoma CMB,desmoplastic medulloblastoma DMB,medulloblastoma with extensive nodularity MBEN,large cell medulloblastoma LCMB and anaplatic medulloblastoma AMB).The low-risk group (＞3 years,M0,complete/near total tumor resection,CMB,DMB/MBEN) received postoperative 24～30 Gy craniospinal irradiation followed by a boost of 54～56 Gy to tumor bed in posterior fossa and then 8 cycles of sequential maintenance chemotherapy.In the high-risk group (≤3 years,M +,tumor residue ≥1.5 em,AMB/LCMB),children aged ＞3 years received two-cycles of postoperative induced chemotherapy,followed by 36 Gy craniospinal irradiation and then a boost of 54～56Gy to tumor bed in posterior fossa,followed by 4 cycles of maintenance chemotherapy after irradiation.Children aged ≤3 years received 3 cycles of postoperative induced chemotherapy followed by 4 cycles of maintenance chemotherapy.Results Among 115 children with histologically confirmed primary medulloblastoma,there were 77 boys and 38 girls with a male-to-female ratio of 2.02 ∶ 1.Eight cases were aged under 3 years and 107 cases older than 3.Therefore the median age was 6.75 years (15 months the youngest and 15 years the oldest).The lowrisk group had 60 children (accounting for 52.2％ of total) while 55 children (accounting for 47.8％) were put in high-risk group.The median follow-up period was 25 (6-60) months.The 3-5 year overall survival (OS) was 85.5％ in low-risk group versus 67.7％ in high-risk group.And significant difference existed between two groups (P＜0.05).In addition,3-5 year disease-free survival (DFS) was 76.8％ in low-risk group while 47.3％ in high-risk group.Two groups showed significant intergroup difference (P＜0.05).Among 31 recurrent cases (27.0％),twoof them were aged ≤3 years.The median time of postoperative recurrence was 12 months (4 weeks to 48 months).Among them,2 obtained complete remission and 13 patients showed partial remission.Another 16 patients died,including 1 patient aged ≤ 3 years.One case suffered secondary intracranial high-grade glioma.Conclusions For diagnosis and therapy stratified on the basis of risk-factors for children with medulloblastoma,survival ratio and quality of life may be improved.The long-term survival of such children has correlation with risk factors.

Prognostic value of imaging classification of medulloblastoma in children

A New Risk Stratification System Based on MRI Features and Machine Learning to Predict Differential Prognosis for Pediatric Medulloblastoma Patients

Analysis of Clinical Prognosis and Risk Factors for Children with Medulloblastoma

Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma.

Impact of tumor location and fourth ventricle infiltration in medulloblastoma

A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience.

MEDB-05. Survival and prognostic factors in childhood medulloblastoma: A China single center experience from 2006 to 2015

[Correlation Between the Prognosis of Medulloblastoma and Relevant Clinical Factors: Analysis of 73 Cases].

MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features

Radiomic signatures based on multiparametric MR images for predicting Ki-67 index expression in medulloblastoma

Clinical characteristics of children with medulloblastoma

Distinctive Localization and MRI Features Correlate of Molecular Subgroups in Adult Medulloblastoma

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis

Preoperative prediction of sonic hedgehog and group 4 molecular subtypes of pediatric medulloblastoma based on radiomics of multiparametric MRI combined with clinical parameters

Clinical and effect analyses of comprehensive treatment for medulloblastoma: a report of 115 children

Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma

Prognostic Significance of MicroRNAs in Medulloblastoma: A Systematic Review and Meta-Analysis

Clinical Outcomes of Adult Medulloblastoma: A Retrospective Analysis at a Single Institute

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment

Accuracy analysis of identifying molecular subtypes of children and adolescents with medulloblastoma using real-time fluorescence quantitative PCR

Application of Individualized Therapy Based on Molecular Classification in the Treatment of Medulloblastoma in Children